US Broker Ratings

Aura Biosciences, Inc. (AURA) Investor Outlook: Exploring a 258% Potential Upside in the Biotechnology Sector

Aura Biosciences, Inc. (AURA), a notable player in the biotechnology sector, is currently drawing significant attention from investors, and for good reason. With a market capitalization of $372.03 million, this..

Neuronetics, Inc. (STIM) Stock Analysis: Evaluating a 77% Potential Upside in Healthcare Innovation

Neuronetics, Inc. (NASDAQ: STIM), a notable player in the medical devices industry, is capturing attention with its innovative approach to treating neurohealth disorders. As a healthcare company specializing in non-invasive..

Nyxoah SA (NYXH) Investor Outlook: Exploring a 63.83% Potential Upside in the Sleep Apnea Market

Nyxoah SA (NYXH), headquartered in Mont-Saint-Guibert, Belgium, is positioned within the healthcare sector, focusing on the medical instruments and supplies industry. Nyxoah specializes in innovative solutions for obstructive sleep apnea..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring the 232.70% Potential Upside in Biotechnology

Abeona Therapeutics Inc. (NASDAQ: ABEO), a promising player in the biotechnology sector, is capturing investor interest with a notable potential upside of 232.70%. Specializing in the development of cutting-edge gene..

AudioEye, Inc. (AEYE) Stock Analysis: A Technology Innovator with 78% Upside Potential

AudioEye, Inc. (NASDAQ: AEYE), a pioneer in the field of digital accessibility, is catching the eye of investors with a compelling growth narrative. Currently trading at $12.55 per share, the..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring 108.84% Potential Upside in the Medical Devices Sector

Investors with a keen eye on the healthcare sector might find Cytek Biosciences, Inc. (NASDAQ: CTKB) an intriguing prospect. As a player in the medical devices industry, Cytek is making..

AMTD Digital Inc. (HKD) Stock Analysis: A Closer Look at Their 15.52% Return on Equity

AMTD Digital Inc. (HKD), a Paris-based player in the Technology sector, is carving out a niche in the Software – Application industry. Despite its modest market capitalization of approximately $615.99..

Fair Isaac Corporation (FICO) Stock Analysis: Uncovering a 35% Potential Upside with Robust Revenue Growth

Fair Isaac Corporation (NYSE: FICO), a prominent player in the technology sector specializing in software applications, is capturing investor attention with its promising financial metrics and market positioning. With a..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Biotech Innovator with an 84% Upside Potential

Cidara Therapeutics, Inc. (NASDAQ: CDTX) presents a compelling opportunity for investors seeking exposure to the dynamic biotechnology sector. With a market capitalization of $294.28 million, this San Diego-based company is..

Mereo BioPharma Group plc (MREO) Stock Analysis: Unpacking a Remarkable 248% Potential Upside

Mereo BioPharma Group plc (NASDAQ: MREO) presents a compelling case for investors eyeing the biotechnology sector, with a notable potential upside of 248.13% based on analyst target prices. As a..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Biotechnology Innovator with a 341.67% Potential Upside

For investors seeking high-growth opportunities in the biotechnology sector, aTyr Pharma, Inc. (NASDAQ: ATYR) presents an intriguing prospect. This San Diego-based clinical-stage biotech company is making strides with its innovative..

Sanara MedTech Inc. (SMTI) Stock Analysis: Exploring a 69% Potential Upside in the Healthcare Sector

Sanara MedTech Inc. (NASDAQ: SMTI), a prominent player in the medical instruments and supplies industry, is currently capturing investor interest with its promising growth potential in the healthcare sector. Headquartered..

Quhuo Limited (QH) Stock Analysis: Navigating Challenges in the Gig Economy Sector

Quhuo Limited, trading under the ticker QH, presents a compelling case for investors interested in the dynamic landscape of the gig economy, particularly within China’s burgeoning on-demand services sector. Despite..

Immutep Limited (IMMP) Stock Analysis: A Potential 392% Upside in the Biotech Arena

Immutep Limited (IMMP), an Australia-based biotechnology firm, is capturing investor attention with its impressive growth potential in the healthcare sector. Known for its innovative LAG-3 immunotherapy developments, Immutep is at..

Viemed Healthcare, Inc. (VMD) Stock Analysis: A 95% Upside Potential in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Viemed Healthcare, Inc. (NASDAQ: VMD) presents a compelling case with its significant upside potential. With a market capitalization of approximately $259.67 million,..

Alpha Teknova, Inc. (TKNO): Investor Outlook on an 89.66% Potential Upside and Analyst Ratings

Alpha Teknova, Inc. (NASDAQ: TKNO) is making waves in the healthcare sector, specifically within the specialized domain of drug manufacturing. As an established player in the United States, the company..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Unpacking a 246% Potential Upside Opportunity

Heron Therapeutics, Inc. (NASDAQ: HRTX) presents a compelling opportunity for investors eyeing the biotechnology sector. With a market capitalization of approximately $279.19 million, Heron Therapeutics stands out not only for..

National Research Corporation (NRC) Stock Analysis: A High ROE Healthcare Play with a Compelling Dividend Yield

National Research Corporation (NASDAQ: NRC) stands out in the healthcare sector, primarily due to its comprehensive suite of analytics and insights solutions designed to enhance patient and employee experiences. With..

Candel Therapeutics, Inc. (CADL) Stock Analysis: An Exciting 264.76% Potential Upside in Cancer Immunotherapy

Candel Therapeutics, Inc. (NASDAQ: CADL), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising portfolio of cancer immunotherapies. With a market capitalization of $297.61 million,..

Checkpoint Therapeutics, Inc. (CKPT) Stock Analysis: Is There More Room to Grow Beyond Its 2.44% Potential Upside?

Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) is garnering attention in the biotechnology sector, a segment known for its innovation and potential high returns. As a commercial-stage immunotherapy and targeted oncology company,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds